内镜下同期放置双侧金属胆道支架治疗肝门部胆管恶性梗阻疗效观察

来源 :中国普外基础与临床杂志 | 被引量 : 0次 | 上传用户:wdelaopologo
下载到本地 , 更方便阅读
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
目的探讨经内镜同期置入双侧可膨式金属胆道支架治疗肝门部胆管恶性梗阻的安全性与有效性。方法收集2007年5月至2010年12月期间因肝门部胆管恶性梗阻而接受内镜下同期双侧金属支架置入患者,记录技术成功率、引流有效率、随访ERCP相关性并发症、支架通畅期与生存期。结果共有24例肝门部胆管恶性梗阻患者接受内镜下同期双侧金属支架置入,完成随访21例,平均随访时间39个月。技术成功率为100%,平均耗时(36.2±13.9)min,引流有效率为95.45%(21/22)。ERCP后发生胆管炎2例,无胰腺炎、消化道出血、穿孔及ERCP相关性死亡病例。7例患者随访期内支架失效,其中4例患者再次置入塑料支架,1例行PTCD后症状缓解,其余2例行保守治疗。支架中位通畅期为253 d(95%CI:199.79~306.21),BismuthⅡ、Ⅲ、Ⅳ型间通畅期差异无统计学意义(P=0.576);中位生存期为229 d(95%CI:154.53~303.47),BismuthⅡ、Ⅲ、Ⅳ型间生存期差异无统计学意义(P=0.748)。结论经内镜同期置入双侧金属支架治疗肝门部胆管恶性梗阻是可行、安全和有效的。 Objective To investigate the safety and efficacy of double-sided expandable metal biliary stent placed endoscopically in the treatment of malignant obstruction of hilar bile duct. Methods The patients with malignant obstruction of hilar biliary tract underwent endoscopic simultaneous metal stent implantation from May 2007 to December 2010 were enrolled. The success rate of the technique, drainage efficiency, follow-up of ERCP-related complications, stent Patency and survival. Results A total of 24 patients with hilar cholangiocarcinoma underwent endoscopic endoscopic bilateral metal stent implantation. Twenty-one patients were followed up with a mean follow-up of 39 months. The technical success rate was 100%, the average time-consuming (36.2 ± 13.9) min, drainage efficiency was 95.45% (21/22). Two cases of cholangitis occurred after ERCP without pancreatitis, gastrointestinal bleeding, perforation and ERCP-related deaths. During the follow-up period, the stent failed in 7 patients. Four patients were re-placed in plastic stent. The symptoms were relieved in 1 patient after PTCD. The remaining 2 patients were treated conservatively. The median duration of patency was 253 days (95% CI: 199.79-306.21). There was no significant difference between the Bismuth II, III and IV types (P = 0.576). The median survival time was 229 days (95% CI: 154.53 ~ 303.47). There was no significant difference in survival time between Bismuth Ⅱ, Ⅲ and Ⅳ (P = 0.748). Conclusions It is feasible, safe and effective to treat the hilar cholangiocarcinoma obstruction by endoscopic simultaneous placement of bilateral metal stents.
其他文献
武汉重工铸锻有限责任公司是集热加工、机加工为一体的企业.每个产品都是从炼钢开始,经过炼钢-锻压-热处理-机加工等生产过程.公司作为耗能大户,每年耗能折标准煤约10万吨.因
肝门部胆管癌(hilar cholangiocarcinoma,HC)因其生物学和解剖学特点,致使外科手术切除困难,术后长期生存率低,临床疗效不佳。首例经胆管引流后再联合肝叶切除治疗HC报道于19
在当代市场经济的大环境下,企业的发展面临着越来越强的竞争和商业风险.成品油作为一种有限资源的产物,是能源企业竞争极为激烈的销售产品之一,企业要保障在成品油市场有着稳
肝门部胆管癌(hilar cholangiocarcinoma,HCC)是指发生于胆囊管开口以上的肝总管和左右肝管的粘膜上皮癌,亦称为高位胆管癌或上段胆管癌。1965年Klatskin首先描述了胆管分叉
期刊
对肝胆外科医生而言,肝门部胆管癌仍然是目前最困难的挑战:肝十二指肠韧带处解剖复杂,胆管分叉与入肝血管过于接近,往往难以获得阴性的外科切缘。我们在临床中对肝门部胆管癌
肝门部胆管癌或称高位胆管癌,是指发生于左右肝管及其汇合部的恶性肿瘤,又称为Klastin瘤,占肝外胆管癌(EHBDC)的58%~75%[1]。根治性手术是肝门部胆管癌患者获得长期生存的惟
病例资料患者,男,77岁,因“左背部皮下包块6个月,包块切除术后20 d”入院.入院前6个月患者发现左背部皮下一包块,有轻微压痛,无红肿、出血、化脓,患者未予特殊处理.入院前20
在油轮运输成品油进行装卸的过程中,都较多的存在油轮装卸中成品油损耗的问题.成品油的损耗原因较多,在油轮运输途中和装卸的过程中总会因为不同的人为因素或者非人为因素导
期刊